KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) EPS (Weighted Average and Diluted) (2016 - 2025)

Labcorp Holdings (LH) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $1.98 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 15.79% to $1.98 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.46 through Dec 2025, up 18.46% year-over-year, with the annual reading at $10.46 for FY2025, 18.33% up from the prior year.
  • EPS (Weighted Average and Diluted) hit $1.98 in Q4 2025 for Labcorp Holdings, down from $3.12 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $7.82 in Q1 2021 to a low of -$1.86 in Q4 2023.
  • Historically, EPS (Weighted Average and Diluted) has averaged $2.92 across 5 years, with a median of $2.6 in 2024.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 339.14% in 2021 and later tumbled 295.79% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at $3.89 in 2021, then tumbled by 75.58% to $0.95 in 2022, then crashed by 295.79% to -$1.86 in 2023, then skyrocketed by 191.94% to $1.71 in 2024, then grew by 15.79% to $1.98 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for LH at $1.98 in Q4 2025, $3.12 in Q3 2025, and $2.84 in Q2 2025.